Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

212,881-212,910 of 319,975

filter-aware
54
The slide uses a three-column layout to define technical requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
55
The slide uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
56
The slide uses a linear process framework to explain the drug discovery pipeline.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
57
The slide uses a Pareto front to illustrate the trade-off between CNS score and Potency, highlighting the selection of 'unattractive' compounds.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
58
The slide shows two charts: a line chart for tumour volume over time and a dot plot for plasma Pro-GRP concentration.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
59
The slide uses two distinct chart types (dot plot and line chart) to demonstrate the safety profile of a reversible inhibitor.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
60
The chart shows a statistically significant difference (****) between the vehicle control and the treatment groups.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
61
The slide uses a two-column layout to contrast PK data with Toxicology/Safety data.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
62
The slide uses a split-layout to contrast current operational status with high-level program benefits.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
63
The slide uses a stylized molecular visualization as a background, typical of biotech pitch decks.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
64
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
65
Scientific/medical context slide explaining a therapeutic target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
66
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
67
The slide uses a scientific mechanism-of-action argument to establish a competitive moat.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
68
The slide uses a heatmap-style table to compare the company's asset against competitors, with a specific callout box around the UGT1A1 row.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
69
The slide uses a process-based framework to show how MD and AI are integrated into a drug discovery workflow.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
70
The image shows a protein binding site with color-coded regions (Donor, Apolar, Acceptor) indicating chemical properties.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
71
The chart displays tumour volume over time (D20-D48) with error bars representing standard deviation and statistical significance markers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
72
The chart shows tumor volume over time (D20-D30), with the combination therapy (teal line) showing a flat growth curve compared to monotherapies and vehicle controls.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
73
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
74
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
75
This is a standard corporate contact/disclaimer slide.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
01
Slide 1
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
02
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a dual-track timeline approach (Pipeline vs Platform/Corporate) for 1H 2023, followed by a list for 2H 2023.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
04
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
05
The diagram represents a closed-loop iterative process for drug discovery.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
06
The slide uses a cyclical process flow to represent an adaptive clinical trial framework.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a visual list of protein structures to represent drug candidates.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
08
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit